nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—type 2 diabetes mellitus—coronary artery disease	0.406	1	CtDrD
Repaglinide—PPARG—coronary artery disease	0.116	0.727	CbGaD
Repaglinide—ALB—coronary artery disease	0.0436	0.273	CbGaD
Repaglinide—PPARG—Telmisartan—coronary artery disease	0.0426	0.139	CbGbCtD
Repaglinide—SLCO1B1—Gemfibrozil—coronary artery disease	0.0193	0.0628	CbGbCtD
Repaglinide—SLCO1B1—Olmesartan—coronary artery disease	0.0183	0.0596	CbGbCtD
Repaglinide—SLCO1B1—Pitavastatin—coronary artery disease	0.0147	0.0476	CbGbCtD
Repaglinide—SLCO1B1—Valsartan—coronary artery disease	0.0143	0.0463	CbGbCtD
Repaglinide—SLCO1B1—Ezetimibe—coronary artery disease	0.0108	0.0351	CbGbCtD
Repaglinide—SLCO1B1—Rosuvastatin—coronary artery disease	0.0108	0.0351	CbGbCtD
Repaglinide—CYP2C8—Fenofibrate—coronary artery disease	0.0102	0.0333	CbGbCtD
Repaglinide—SLCO1B1—Simvastatin—coronary artery disease	0.01	0.0326	CbGbCtD
Repaglinide—SLCO1B1—Pravastatin—coronary artery disease	0.00983	0.0319	CbGbCtD
Repaglinide—SLCO1B1—Lovastatin—coronary artery disease	0.00983	0.0319	CbGbCtD
Repaglinide—SLCO1B1—Atorvastatin—coronary artery disease	0.00895	0.0291	CbGbCtD
Repaglinide—SLCO1B1—Losartan—coronary artery disease	0.00819	0.0266	CbGbCtD
Repaglinide—CYP2C8—Gemfibrozil—coronary artery disease	0.00818	0.0266	CbGbCtD
Repaglinide—ALB—Pitavastatin—coronary artery disease	0.00803	0.0261	CbGbCtD
Repaglinide—ALB—Valsartan—coronary artery disease	0.00781	0.0254	CbGbCtD
Repaglinide—CYP2C8—Clopidogrel—coronary artery disease	0.0071	0.0231	CbGbCtD
Repaglinide—CYP2C8—Pitavastatin—coronary artery disease	0.0062	0.0201	CbGbCtD
Repaglinide—ALB—Rosuvastatin—coronary artery disease	0.00592	0.0192	CbGbCtD
Repaglinide—ALB—Acetylsalicylic acid—coronary artery disease	0.00577	0.0187	CbGbCtD
Repaglinide—ALB—Captopril—coronary artery disease	0.0057	0.0185	CbGbCtD
Repaglinide—CYP3A4—Ticagrelor—coronary artery disease	0.00466	0.0151	CbGbCtD
Repaglinide—ALB—Furosemide—coronary artery disease	0.00458	0.0149	CbGbCtD
Repaglinide—ALB—Losartan—coronary artery disease	0.00448	0.0146	CbGbCtD
Repaglinide—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00446	0.0145	CbGbCtD
Repaglinide—CYP2C8—Simvastatin—coronary artery disease	0.00425	0.0138	CbGbCtD
Repaglinide—CYP2C8—Pravastatin—coronary artery disease	0.00416	0.0135	CbGbCtD
Repaglinide—CYP2C8—Lovastatin—coronary artery disease	0.00416	0.0135	CbGbCtD
Repaglinide—CYP3A4—Fenofibrate—coronary artery disease	0.00415	0.0135	CbGbCtD
Repaglinide—CYP2C8—Atorvastatin—coronary artery disease	0.00379	0.0123	CbGbCtD
Repaglinide—CYP2C8—Losartan—coronary artery disease	0.00347	0.0113	CbGbCtD
Repaglinide—CYP3A4—Gemfibrozil—coronary artery disease	0.00332	0.0108	CbGbCtD
Repaglinide—CYP3A4—Clopidogrel—coronary artery disease	0.00288	0.00935	CbGbCtD
Repaglinide—CYP3A4—Eplerenone—coronary artery disease	0.00268	0.00869	CbGbCtD
Repaglinide—CYP3A4—Enalapril—coronary artery disease	0.00238	0.00775	CbGbCtD
Repaglinide—CYP3A4—Rosuvastatin—coronary artery disease	0.00185	0.00602	CbGbCtD
Repaglinide—CYP3A4—Ezetimibe—coronary artery disease	0.00185	0.00602	CbGbCtD
Repaglinide—CYP3A4—Simvastatin—coronary artery disease	0.00172	0.0056	CbGbCtD
Repaglinide—CYP3A4—Pravastatin—coronary artery disease	0.00169	0.00548	CbGbCtD
Repaglinide—CYP3A4—Lovastatin—coronary artery disease	0.00169	0.00548	CbGbCtD
Repaglinide—CYP3A4—Atorvastatin—coronary artery disease	0.00154	0.00499	CbGbCtD
Repaglinide—CYP3A4—Losartan—coronary artery disease	0.00141	0.00457	CbGbCtD
Repaglinide—Diarrhoea—Fenofibrate—coronary artery disease	5.48e-05	0.000683	CcSEcCtD
Repaglinide—Thrombocytopenia—Losartan—coronary artery disease	5.47e-05	0.000682	CcSEcCtD
Repaglinide—Constipation—Enalapril—coronary artery disease	5.47e-05	0.000682	CcSEcCtD
Repaglinide—Arrhythmia—Lisinopril—coronary artery disease	5.46e-05	0.000681	CcSEcCtD
Repaglinide—Urticaria—Olmesartan—coronary artery disease	5.46e-05	0.000681	CcSEcCtD
Repaglinide—Abdominal pain—Valsartan—coronary artery disease	5.46e-05	0.000681	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Telmisartan—coronary artery disease	5.44e-05	0.000679	CcSEcCtD
Repaglinide—Abdominal pain—Olmesartan—coronary artery disease	5.43e-05	0.000677	CcSEcCtD
Repaglinide—Pruritus—Ezetimibe—coronary artery disease	5.42e-05	0.000677	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Perindopril—coronary artery disease	5.42e-05	0.000677	CcSEcCtD
Repaglinide—Gastrointestinal pain—Pravastatin—coronary artery disease	5.4e-05	0.000674	CcSEcCtD
Repaglinide—Alopecia—Lisinopril—coronary artery disease	5.4e-05	0.000674	CcSEcCtD
Repaglinide—Dyspepsia—Captopril—coronary artery disease	5.4e-05	0.000673	CcSEcCtD
Repaglinide—Constipation—Telmisartan—coronary artery disease	5.39e-05	0.000673	CcSEcCtD
Repaglinide—Hypersensitivity—Simvastatin—coronary artery disease	5.39e-05	0.000672	CcSEcCtD
Repaglinide—Diarrhoea—Clopidogrel—coronary artery disease	5.38e-05	0.000672	CcSEcCtD
Repaglinide—Diarrhoea—Lovastatin—coronary artery disease	5.35e-05	0.000667	CcSEcCtD
Repaglinide—Paraesthesia—Perindopril—coronary artery disease	5.34e-05	0.000667	CcSEcCtD
Repaglinide—Urticaria—Niacin—coronary artery disease	5.33e-05	0.000665	CcSEcCtD
Repaglinide—Nausea—Acetylsalicylic acid—coronary artery disease	5.32e-05	0.000664	CcSEcCtD
Repaglinide—Malnutrition—Lisinopril—coronary artery disease	5.32e-05	0.000664	CcSEcCtD
Repaglinide—Erythema—Lisinopril—coronary artery disease	5.32e-05	0.000664	CcSEcCtD
Repaglinide—Pruritus—Eplerenone—coronary artery disease	5.31e-05	0.000662	CcSEcCtD
Repaglinide—Abdominal pain—Niacin—coronary artery disease	5.31e-05	0.000662	CcSEcCtD
Repaglinide—Leukopenia—Ramipril—coronary artery disease	5.25e-05	0.000655	CcSEcCtD
Repaglinide—Urticaria—Pravastatin—coronary artery disease	5.25e-05	0.000655	CcSEcCtD
Repaglinide—Gastrointestinal pain—Trandolapril—coronary artery disease	5.25e-05	0.000655	CcSEcCtD
Repaglinide—Diarrhoea—Ezetimibe—coronary artery disease	5.24e-05	0.000654	CcSEcCtD
Repaglinide—Constipation—Captopril—coronary artery disease	5.24e-05	0.000654	CcSEcCtD
Repaglinide—Dyspepsia—Perindopril—coronary artery disease	5.24e-05	0.000654	CcSEcCtD
Repaglinide—Gastrointestinal pain—Enalapril—coronary artery disease	5.23e-05	0.000652	CcSEcCtD
Repaglinide—Abdominal pain—Pravastatin—coronary artery disease	5.22e-05	0.000652	CcSEcCtD
Repaglinide—Paraesthesia—Furosemide—coronary artery disease	5.2e-05	0.000648	CcSEcCtD
Repaglinide—Palpitations—Ramipril—coronary artery disease	5.18e-05	0.000647	CcSEcCtD
Repaglinide—Pruritus—Simvastatin—coronary artery disease	5.17e-05	0.000645	CcSEcCtD
Repaglinide—Gastrointestinal pain—Telmisartan—coronary artery disease	5.16e-05	0.000643	CcSEcCtD
Repaglinide—Back pain—Lisinopril—coronary artery disease	5.15e-05	0.000642	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Perindopril—coronary artery disease	5.14e-05	0.000641	CcSEcCtD
Repaglinide—Diarrhoea—Eplerenone—coronary artery disease	5.13e-05	0.00064	CcSEcCtD
Repaglinide—Urticaria—Trandolapril—coronary artery disease	5.1e-05	0.000636	CcSEcCtD
Repaglinide—Constipation—Perindopril—coronary artery disease	5.09e-05	0.000635	CcSEcCtD
Repaglinide—Vomiting—Fenofibrate—coronary artery disease	5.09e-05	0.000635	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Losartan—coronary artery disease	5.09e-05	0.000635	CcSEcCtD
Repaglinide—Hypersensitivity—Valsartan—coronary artery disease	5.09e-05	0.000634	CcSEcCtD
Repaglinide—Urticaria—Enalapril—coronary artery disease	5.08e-05	0.000633	CcSEcCtD
Repaglinide—Abdominal pain—Trandolapril—coronary artery disease	5.07e-05	0.000633	CcSEcCtD
Repaglinide—Palpitations—Timolol—coronary artery disease	5.07e-05	0.000632	CcSEcCtD
Repaglinide—Abdominal pain—Enalapril—coronary artery disease	5.05e-05	0.00063	CcSEcCtD
Repaglinide—Rash—Fenofibrate—coronary artery disease	5.05e-05	0.00063	CcSEcCtD
Repaglinide—Dermatitis—Fenofibrate—coronary artery disease	5.04e-05	0.000629	CcSEcCtD
Repaglinide—Headache—Fenofibrate—coronary artery disease	5.01e-05	0.000625	CcSEcCtD
Repaglinide—Paraesthesia—Losartan—coronary artery disease	5.01e-05	0.000625	CcSEcCtD
Repaglinide—Gastrointestinal pain—Captopril—coronary artery disease	5.01e-05	0.000625	CcSEcCtD
Repaglinide—Urticaria—Telmisartan—coronary artery disease	5.01e-05	0.000625	CcSEcCtD
Repaglinide—Vomiting—Clopidogrel—coronary artery disease	5e-05	0.000624	CcSEcCtD
Repaglinide—Diarrhoea—Simvastatin—coronary artery disease	5e-05	0.000624	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Furosemide—coronary artery disease	5e-05	0.000623	CcSEcCtD
Repaglinide—Arthralgia—Ramipril—coronary artery disease	4.99e-05	0.000623	CcSEcCtD
Repaglinide—Chest pain—Ramipril—coronary artery disease	4.99e-05	0.000623	CcSEcCtD
Repaglinide—Abdominal pain—Telmisartan—coronary artery disease	4.98e-05	0.000622	CcSEcCtD
Repaglinide—Vomiting—Lovastatin—coronary artery disease	4.97e-05	0.00062	CcSEcCtD
Repaglinide—Rash—Clopidogrel—coronary artery disease	4.96e-05	0.000619	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	4.96e-05	0.000619	CcSEcCtD
Repaglinide—Dermatitis—Clopidogrel—coronary artery disease	4.96e-05	0.000618	CcSEcCtD
Repaglinide—Hypertension—Timolol—coronary artery disease	4.95e-05	0.000618	CcSEcCtD
Repaglinide—Constipation—Furosemide—coronary artery disease	4.95e-05	0.000617	CcSEcCtD
Repaglinide—Hypersensitivity—Niacin—coronary artery disease	4.95e-05	0.000617	CcSEcCtD
Repaglinide—Headache—Clopidogrel—coronary artery disease	4.93e-05	0.000615	CcSEcCtD
Repaglinide—Rash—Lovastatin—coronary artery disease	4.93e-05	0.000615	CcSEcCtD
Repaglinide—Dermatitis—Lovastatin—coronary artery disease	4.92e-05	0.000614	CcSEcCtD
Repaglinide—Dyspepsia—Losartan—coronary artery disease	4.91e-05	0.000613	CcSEcCtD
Repaglinide—Headache—Lovastatin—coronary artery disease	4.9e-05	0.000611	CcSEcCtD
Repaglinide—Pruritus—Valsartan—coronary artery disease	4.88e-05	0.000609	CcSEcCtD
Repaglinide—Arthralgia—Timolol—coronary artery disease	4.88e-05	0.000609	CcSEcCtD
Repaglinide—Chest pain—Timolol—coronary artery disease	4.88e-05	0.000609	CcSEcCtD
Repaglinide—Vomiting—Ezetimibe—coronary artery disease	4.87e-05	0.000608	CcSEcCtD
Repaglinide—Hypersensitivity—Pravastatin—coronary artery disease	4.87e-05	0.000607	CcSEcCtD
Repaglinide—Gastrointestinal pain—Perindopril—coronary artery disease	4.87e-05	0.000607	CcSEcCtD
Repaglinide—Pruritus—Olmesartan—coronary artery disease	4.86e-05	0.000606	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	4.85e-05	0.000605	CcSEcCtD
Repaglinide—Abdominal pain—Captopril—coronary artery disease	4.85e-05	0.000605	CcSEcCtD
Repaglinide—Rash—Ezetimibe—coronary artery disease	4.83e-05	0.000603	CcSEcCtD
Repaglinide—Dermatitis—Ezetimibe—coronary artery disease	4.83e-05	0.000602	CcSEcCtD
Repaglinide—Headache—Ezetimibe—coronary artery disease	4.8e-05	0.000599	CcSEcCtD
Repaglinide—Oedema—Ramipril—coronary artery disease	4.79e-05	0.000597	CcSEcCtD
Repaglinide—Anaphylactic shock—Ramipril—coronary artery disease	4.79e-05	0.000597	CcSEcCtD
Repaglinide—Constipation—Losartan—coronary artery disease	4.77e-05	0.000596	CcSEcCtD
Repaglinide—Vomiting—Eplerenone—coronary artery disease	4.77e-05	0.000595	CcSEcCtD
Repaglinide—Leukopenia—Lisinopril—coronary artery disease	4.76e-05	0.000594	CcSEcCtD
Repaglinide—Nausea—Fenofibrate—coronary artery disease	4.75e-05	0.000593	CcSEcCtD
Repaglinide—Pruritus—Niacin—coronary artery disease	4.75e-05	0.000592	CcSEcCtD
Repaglinide—Gastrointestinal pain—Furosemide—coronary artery disease	4.73e-05	0.00059	CcSEcCtD
Repaglinide—Rash—Eplerenone—coronary artery disease	4.73e-05	0.00059	CcSEcCtD
Repaglinide—Urticaria—Perindopril—coronary artery disease	4.73e-05	0.00059	CcSEcCtD
Repaglinide—Hypersensitivity—Trandolapril—coronary artery disease	4.73e-05	0.00059	CcSEcCtD
Repaglinide—Dermatitis—Eplerenone—coronary artery disease	4.73e-05	0.00059	CcSEcCtD
Repaglinide—Diarrhoea—Valsartan—coronary artery disease	4.72e-05	0.000589	CcSEcCtD
Repaglinide—Hypersensitivity—Enalapril—coronary artery disease	4.71e-05	0.000587	CcSEcCtD
Repaglinide—Abdominal pain—Perindopril—coronary artery disease	4.71e-05	0.000587	CcSEcCtD
Repaglinide—Palpitations—Lisinopril—coronary artery disease	4.7e-05	0.000586	CcSEcCtD
Repaglinide—Diarrhoea—Olmesartan—coronary artery disease	4.7e-05	0.000586	CcSEcCtD
Repaglinide—Headache—Eplerenone—coronary artery disease	4.7e-05	0.000586	CcSEcCtD
Repaglinide—Thrombocytopenia—Ramipril—coronary artery disease	4.69e-05	0.000585	CcSEcCtD
Repaglinide—Oedema—Timolol—coronary artery disease	4.68e-05	0.000584	CcSEcCtD
Repaglinide—Anaphylactic shock—Timolol—coronary artery disease	4.68e-05	0.000584	CcSEcCtD
Repaglinide—Pruritus—Pravastatin—coronary artery disease	4.68e-05	0.000583	CcSEcCtD
Repaglinide—Nausea—Clopidogrel—coronary artery disease	4.67e-05	0.000583	CcSEcCtD
Repaglinide—Skin disorder—Ramipril—coronary artery disease	4.65e-05	0.00058	CcSEcCtD
Repaglinide—Vomiting—Simvastatin—coronary artery disease	4.65e-05	0.00058	CcSEcCtD
Repaglinide—Hypersensitivity—Telmisartan—coronary artery disease	4.64e-05	0.000579	CcSEcCtD
Repaglinide—Nausea—Lovastatin—coronary artery disease	4.64e-05	0.000579	CcSEcCtD
Repaglinide—Rash—Simvastatin—coronary artery disease	4.61e-05	0.000575	CcSEcCtD
Repaglinide—Dermatitis—Simvastatin—coronary artery disease	4.6e-05	0.000574	CcSEcCtD
Repaglinide—Urticaria—Furosemide—coronary artery disease	4.6e-05	0.000573	CcSEcCtD
Repaglinide—Diarrhoea—Niacin—coronary artery disease	4.59e-05	0.000573	CcSEcCtD
Repaglinide—Headache—Simvastatin—coronary artery disease	4.58e-05	0.000571	CcSEcCtD
Repaglinide—Abdominal pain—Furosemide—coronary artery disease	4.57e-05	0.000571	CcSEcCtD
Repaglinide—Gastrointestinal pain—Losartan—coronary artery disease	4.57e-05	0.00057	CcSEcCtD
Repaglinide—Nausea—Ezetimibe—coronary artery disease	4.55e-05	0.000568	CcSEcCtD
Repaglinide—Skin disorder—Timolol—coronary artery disease	4.55e-05	0.000567	CcSEcCtD
Repaglinide—Pruritus—Trandolapril—coronary artery disease	4.54e-05	0.000566	CcSEcCtD
Repaglinide—Chest pain—Lisinopril—coronary artery disease	4.53e-05	0.000565	CcSEcCtD
Repaglinide—Arthralgia—Lisinopril—coronary artery disease	4.53e-05	0.000565	CcSEcCtD
Repaglinide—Pruritus—Enalapril—coronary artery disease	4.52e-05	0.000564	CcSEcCtD
Repaglinide—Diarrhoea—Pravastatin—coronary artery disease	4.52e-05	0.000564	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	4.5e-05	0.000561	CcSEcCtD
Repaglinide—Pruritus—Telmisartan—coronary artery disease	4.46e-05	0.000556	CcSEcCtD
Repaglinide—Nausea—Eplerenone—coronary artery disease	4.46e-05	0.000556	CcSEcCtD
Repaglinide—Urticaria—Losartan—coronary artery disease	4.44e-05	0.000553	CcSEcCtD
Repaglinide—Abdominal pain—Losartan—coronary artery disease	4.41e-05	0.000551	CcSEcCtD
Repaglinide—Diarrhoea—Trandolapril—coronary artery disease	4.39e-05	0.000548	CcSEcCtD
Repaglinide—Vomiting—Valsartan—coronary artery disease	4.39e-05	0.000548	CcSEcCtD
Repaglinide—Diarrhoea—Enalapril—coronary artery disease	4.37e-05	0.000546	CcSEcCtD
Repaglinide—Vomiting—Olmesartan—coronary artery disease	4.37e-05	0.000545	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.36e-05	0.000544	CcSEcCtD
Repaglinide—Rash—Valsartan—coronary artery disease	4.35e-05	0.000543	CcSEcCtD
Repaglinide—Dermatitis—Valsartan—coronary artery disease	4.35e-05	0.000542	CcSEcCtD
Repaglinide—Nausea—Simvastatin—coronary artery disease	4.34e-05	0.000542	CcSEcCtD
Repaglinide—Oedema—Lisinopril—coronary artery disease	4.34e-05	0.000542	CcSEcCtD
Repaglinide—Anaphylactic shock—Lisinopril—coronary artery disease	4.34e-05	0.000542	CcSEcCtD
Repaglinide—Pruritus—Captopril—coronary artery disease	4.34e-05	0.000541	CcSEcCtD
Repaglinide—Rash—Olmesartan—coronary artery disease	4.33e-05	0.00054	CcSEcCtD
Repaglinide—Dermatitis—Olmesartan—coronary artery disease	4.33e-05	0.00054	CcSEcCtD
Repaglinide—Headache—Valsartan—coronary artery disease	4.32e-05	0.000539	CcSEcCtD
Repaglinide—Diarrhoea—Telmisartan—coronary artery disease	4.31e-05	0.000538	CcSEcCtD
Repaglinide—Headache—Olmesartan—coronary artery disease	4.3e-05	0.000537	CcSEcCtD
Repaglinide—Paraesthesia—Ramipril—coronary artery disease	4.3e-05	0.000536	CcSEcCtD
Repaglinide—Vomiting—Niacin—coronary artery disease	4.27e-05	0.000532	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Timolol—coronary artery disease	4.26e-05	0.000532	CcSEcCtD
Repaglinide—Hypersensitivity—Furosemide—coronary artery disease	4.26e-05	0.000532	CcSEcCtD
Repaglinide—Thrombocytopenia—Lisinopril—coronary artery disease	4.25e-05	0.00053	CcSEcCtD
Repaglinide—Rash—Niacin—coronary artery disease	4.23e-05	0.000528	CcSEcCtD
Repaglinide—Dermatitis—Niacin—coronary artery disease	4.23e-05	0.000527	CcSEcCtD
Repaglinide—Skin disorder—Lisinopril—coronary artery disease	4.22e-05	0.000526	CcSEcCtD
Repaglinide—Dyspepsia—Ramipril—coronary artery disease	4.21e-05	0.000526	CcSEcCtD
Repaglinide—Pruritus—Perindopril—coronary artery disease	4.21e-05	0.000525	CcSEcCtD
Repaglinide—Headache—Niacin—coronary artery disease	4.2e-05	0.000525	CcSEcCtD
Repaglinide—Paraesthesia—Timolol—coronary artery disease	4.2e-05	0.000524	CcSEcCtD
Repaglinide—Vomiting—Pravastatin—coronary artery disease	4.2e-05	0.000524	CcSEcCtD
Repaglinide—Diarrhoea—Captopril—coronary artery disease	4.19e-05	0.000523	CcSEcCtD
Repaglinide—Rash—Pravastatin—coronary artery disease	4.17e-05	0.00052	CcSEcCtD
Repaglinide—Dermatitis—Pravastatin—coronary artery disease	4.16e-05	0.000519	CcSEcCtD
Repaglinide—Headache—Pravastatin—coronary artery disease	4.14e-05	0.000516	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Ramipril—coronary artery disease	4.13e-05	0.000516	CcSEcCtD
Repaglinide—Dyspepsia—Timolol—coronary artery disease	4.12e-05	0.000514	CcSEcCtD
Repaglinide—Hypersensitivity—Losartan—coronary artery disease	4.11e-05	0.000513	CcSEcCtD
Repaglinide—Nausea—Valsartan—coronary artery disease	4.1e-05	0.000512	CcSEcCtD
Repaglinide—Pruritus—Furosemide—coronary artery disease	4.09e-05	0.000511	CcSEcCtD
Repaglinide—Constipation—Ramipril—coronary artery disease	4.09e-05	0.000511	CcSEcCtD
Repaglinide—Nausea—Olmesartan—coronary artery disease	4.08e-05	0.000509	CcSEcCtD
Repaglinide—Vomiting—Trandolapril—coronary artery disease	4.08e-05	0.000509	CcSEcCtD
Repaglinide—Diarrhoea—Perindopril—coronary artery disease	4.07e-05	0.000508	CcSEcCtD
Repaglinide—Vomiting—Enalapril—coronary artery disease	4.06e-05	0.000507	CcSEcCtD
Repaglinide—Rash—Trandolapril—coronary artery disease	4.05e-05	0.000505	CcSEcCtD
Repaglinide—Dermatitis—Trandolapril—coronary artery disease	4.04e-05	0.000504	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Timolol—coronary artery disease	4.04e-05	0.000504	CcSEcCtD
Repaglinide—Rash—Enalapril—coronary artery disease	4.03e-05	0.000503	CcSEcCtD
Repaglinide—Dermatitis—Enalapril—coronary artery disease	4.03e-05	0.000502	CcSEcCtD
Repaglinide—Headache—Trandolapril—coronary artery disease	4.02e-05	0.000502	CcSEcCtD
Repaglinide—Vomiting—Telmisartan—coronary artery disease	4.01e-05	0.0005	CcSEcCtD
Repaglinide—Headache—Enalapril—coronary artery disease	4e-05	0.0005	CcSEcCtD
Repaglinide—Nausea—Niacin—coronary artery disease	3.99e-05	0.000497	CcSEcCtD
Repaglinide—Rash—Telmisartan—coronary artery disease	3.98e-05	0.000496	CcSEcCtD
Repaglinide—Dermatitis—Telmisartan—coronary artery disease	3.97e-05	0.000495	CcSEcCtD
Repaglinide—Diarrhoea—Furosemide—coronary artery disease	3.96e-05	0.000494	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.96e-05	0.000493	CcSEcCtD
Repaglinide—Pruritus—Losartan—coronary artery disease	3.95e-05	0.000493	CcSEcCtD
Repaglinide—Headache—Telmisartan—coronary artery disease	3.95e-05	0.000493	CcSEcCtD
Repaglinide—Nausea—Pravastatin—coronary artery disease	3.93e-05	0.00049	CcSEcCtD
Repaglinide—Gastrointestinal pain—Ramipril—coronary artery disease	3.91e-05	0.000488	CcSEcCtD
Repaglinide—Paraesthesia—Lisinopril—coronary artery disease	3.9e-05	0.000486	CcSEcCtD
Repaglinide—Vomiting—Captopril—coronary artery disease	3.9e-05	0.000486	CcSEcCtD
Repaglinide—Rash—Captopril—coronary artery disease	3.87e-05	0.000482	CcSEcCtD
Repaglinide—Dermatitis—Captopril—coronary artery disease	3.86e-05	0.000482	CcSEcCtD
Repaglinide—Headache—Captopril—coronary artery disease	3.84e-05	0.000479	CcSEcCtD
Repaglinide—Gastrointestinal pain—Timolol—coronary artery disease	3.83e-05	0.000477	CcSEcCtD
Repaglinide—Dyspepsia—Lisinopril—coronary artery disease	3.82e-05	0.000477	CcSEcCtD
Repaglinide—Diarrhoea—Losartan—coronary artery disease	3.82e-05	0.000477	CcSEcCtD
Repaglinide—Nausea—Trandolapril—coronary artery disease	3.81e-05	0.000476	CcSEcCtD
Repaglinide—Urticaria—Ramipril—coronary artery disease	3.8e-05	0.000474	CcSEcCtD
Repaglinide—Nausea—Enalapril—coronary artery disease	3.8e-05	0.000474	CcSEcCtD
Repaglinide—Vomiting—Perindopril—coronary artery disease	3.78e-05	0.000472	CcSEcCtD
Repaglinide—Abdominal pain—Ramipril—coronary artery disease	3.78e-05	0.000472	CcSEcCtD
Repaglinide—Rash—Perindopril—coronary artery disease	3.75e-05	0.000468	CcSEcCtD
Repaglinide—Dermatitis—Perindopril—coronary artery disease	3.75e-05	0.000468	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.75e-05	0.000468	CcSEcCtD
Repaglinide—Nausea—Telmisartan—coronary artery disease	3.74e-05	0.000467	CcSEcCtD
Repaglinide—Headache—Perindopril—coronary artery disease	3.73e-05	0.000465	CcSEcCtD
Repaglinide—Urticaria—Timolol—coronary artery disease	3.72e-05	0.000464	CcSEcCtD
Repaglinide—Constipation—Lisinopril—coronary artery disease	3.71e-05	0.000463	CcSEcCtD
Repaglinide—Abdominal pain—Timolol—coronary artery disease	3.7e-05	0.000462	CcSEcCtD
Repaglinide—Vomiting—Furosemide—coronary artery disease	3.68e-05	0.000459	CcSEcCtD
Repaglinide—Rash—Furosemide—coronary artery disease	3.65e-05	0.000455	CcSEcCtD
Repaglinide—Dermatitis—Furosemide—coronary artery disease	3.65e-05	0.000455	CcSEcCtD
Repaglinide—Nausea—Captopril—coronary artery disease	3.64e-05	0.000454	CcSEcCtD
Repaglinide—Headache—Furosemide—coronary artery disease	3.62e-05	0.000452	CcSEcCtD
Repaglinide—Gastrointestinal pain—Lisinopril—coronary artery disease	3.55e-05	0.000443	CcSEcCtD
Repaglinide—Vomiting—Losartan—coronary artery disease	3.55e-05	0.000443	CcSEcCtD
Repaglinide—Nausea—Perindopril—coronary artery disease	3.54e-05	0.000441	CcSEcCtD
Repaglinide—Hypersensitivity—Ramipril—coronary artery disease	3.53e-05	0.00044	CcSEcCtD
Repaglinide—Rash—Losartan—coronary artery disease	3.52e-05	0.000439	CcSEcCtD
Repaglinide—Dermatitis—Losartan—coronary artery disease	3.52e-05	0.000439	CcSEcCtD
Repaglinide—Headache—Losartan—coronary artery disease	3.5e-05	0.000436	CcSEcCtD
Repaglinide—Urticaria—Lisinopril—coronary artery disease	3.45e-05	0.00043	CcSEcCtD
Repaglinide—Hypersensitivity—Timolol—coronary artery disease	3.45e-05	0.00043	CcSEcCtD
Repaglinide—Nausea—Furosemide—coronary artery disease	3.44e-05	0.000429	CcSEcCtD
Repaglinide—Abdominal pain—Lisinopril—coronary artery disease	3.43e-05	0.000428	CcSEcCtD
Repaglinide—Pruritus—Ramipril—coronary artery disease	3.39e-05	0.000423	CcSEcCtD
Repaglinide—Nausea—Losartan—coronary artery disease	3.32e-05	0.000414	CcSEcCtD
Repaglinide—Pruritus—Timolol—coronary artery disease	3.31e-05	0.000413	CcSEcCtD
Repaglinide—Diarrhoea—Ramipril—coronary artery disease	3.28e-05	0.000409	CcSEcCtD
Repaglinide—Diarrhoea—Timolol—coronary artery disease	3.2e-05	0.000399	CcSEcCtD
Repaglinide—Hypersensitivity—Lisinopril—coronary artery disease	3.2e-05	0.000399	CcSEcCtD
Repaglinide—Pruritus—Lisinopril—coronary artery disease	3.07e-05	0.000383	CcSEcCtD
Repaglinide—Vomiting—Ramipril—coronary artery disease	3.04e-05	0.00038	CcSEcCtD
Repaglinide—Rash—Ramipril—coronary artery disease	3.02e-05	0.000377	CcSEcCtD
Repaglinide—Dermatitis—Ramipril—coronary artery disease	3.02e-05	0.000376	CcSEcCtD
Repaglinide—Headache—Ramipril—coronary artery disease	3e-05	0.000374	CcSEcCtD
Repaglinide—Vomiting—Timolol—coronary artery disease	2.98e-05	0.000371	CcSEcCtD
Repaglinide—Diarrhoea—Lisinopril—coronary artery disease	2.97e-05	0.000371	CcSEcCtD
Repaglinide—Rash—Timolol—coronary artery disease	2.95e-05	0.000368	CcSEcCtD
Repaglinide—Dermatitis—Timolol—coronary artery disease	2.95e-05	0.000368	CcSEcCtD
Repaglinide—Headache—Timolol—coronary artery disease	2.93e-05	0.000366	CcSEcCtD
Repaglinide—Nausea—Ramipril—coronary artery disease	2.84e-05	0.000355	CcSEcCtD
Repaglinide—Nausea—Timolol—coronary artery disease	2.78e-05	0.000347	CcSEcCtD
Repaglinide—Vomiting—Lisinopril—coronary artery disease	2.76e-05	0.000344	CcSEcCtD
Repaglinide—Rash—Lisinopril—coronary artery disease	2.74e-05	0.000341	CcSEcCtD
Repaglinide—Dermatitis—Lisinopril—coronary artery disease	2.73e-05	0.000341	CcSEcCtD
Repaglinide—Headache—Lisinopril—coronary artery disease	2.72e-05	0.000339	CcSEcCtD
Repaglinide—Nausea—Lisinopril—coronary artery disease	2.58e-05	0.000322	CcSEcCtD
Repaglinide—SLCO1B1—Metabolism—GSTP1—coronary artery disease	3.32e-06	7.1e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—P4HB—coronary artery disease	3.32e-06	7.1e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AK1—coronary artery disease	3.31e-06	7.1e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GCH1—coronary artery disease	3.31e-06	7.1e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	3.3e-06	7.07e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS2—coronary artery disease	3.29e-06	7.05e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARGC1A—coronary artery disease	3.29e-06	7.04e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	3.28e-06	7.03e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLA2G1B—coronary artery disease	3.27e-06	7.01e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—HMOX1—coronary artery disease	3.27e-06	7e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLA2G1B—coronary artery disease	3.25e-06	6.97e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AGT—coronary artery disease	3.25e-06	6.96e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.24e-06	6.93e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NOS3—coronary artery disease	3.23e-06	6.91e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CAT—coronary artery disease	3.23e-06	6.91e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.22e-06	6.89e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SERPINE1—coronary artery disease	3.21e-06	6.88e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.2e-06	6.85e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOE—coronary artery disease	3.18e-06	6.82e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.18e-06	6.81e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—UGCG—coronary artery disease	3.18e-06	6.8e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MDH2—coronary artery disease	3.18e-06	6.8e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPAT—coronary artery disease	3.18e-06	6.8e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLCD1—coronary artery disease	3.18e-06	6.8e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOA1—coronary artery disease	3.15e-06	6.74e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOB—coronary artery disease	3.13e-06	6.71e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—VCAN—coronary artery disease	3.09e-06	6.61e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—VCAN—coronary artery disease	3.07e-06	6.57e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDOA—coronary artery disease	3.06e-06	6.55e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PGM1—coronary artery disease	3.06e-06	6.55e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTM1—coronary artery disease	3.05e-06	6.53e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—coronary artery disease	3.04e-06	6.52e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDOA—coronary artery disease	3.04e-06	6.52e-05	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.02e-06	6.48e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.01e-06	6.46e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—LPL—coronary artery disease	2.99e-06	6.41e-05	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—coronary artery disease	2.99e-06	6.4e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—DCN—coronary artery disease	2.97e-06	6.36e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—DCN—coronary artery disease	2.95e-06	6.33e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PYGB—coronary artery disease	2.95e-06	6.33e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CKB—coronary artery disease	2.95e-06	6.33e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—coronary artery disease	2.95e-06	6.32e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IGF1—coronary artery disease	2.92e-06	6.25e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GPX1—coronary artery disease	2.92e-06	6.25e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDH2—coronary artery disease	2.89e-06	6.19e-05	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	2.89e-06	6.19e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDH2—coronary artery disease	2.87e-06	6.15e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CD36—coronary artery disease	2.84e-06	6.09e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.82e-06	6.04e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LIPC—coronary artery disease	2.82e-06	6.03e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HBA1—coronary artery disease	2.82e-06	6.03e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3C2A—coronary artery disease	2.82e-06	6.03e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP2C19—coronary artery disease	2.82e-06	6.03e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPP2CA—coronary artery disease	2.81e-06	6.01e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.8e-06	6e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HBA1—coronary artery disease	2.8e-06	6e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LIPC—coronary artery disease	2.8e-06	6e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3C2A—coronary artery disease	2.8e-06	6e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP2C19—coronary artery disease	2.8e-06	6e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOC3—coronary artery disease	2.8e-06	6e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOC3—coronary artery disease	2.78e-06	5.96e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LDLR—coronary artery disease	2.78e-06	5.96e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.78e-06	5.95e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PFKFB3—coronary artery disease	2.78e-06	5.95e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—COX5B—coronary artery disease	2.78e-06	5.95e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—DLAT—coronary artery disease	2.78e-06	5.95e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTM2—coronary artery disease	2.78e-06	5.95e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLIN1—coronary artery disease	2.78e-06	5.95e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SERPINE1—coronary artery disease	2.77e-06	5.94e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LDLR—coronary artery disease	2.77e-06	5.92e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.76e-06	5.92e-05	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—coronary artery disease	2.76e-06	5.9e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC9A1—coronary artery disease	2.75e-06	5.89e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTT1—coronary artery disease	2.75e-06	5.89e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—POMC—coronary artery disease	2.74e-06	5.86e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTT1—coronary artery disease	2.73e-06	5.85e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC9A1—coronary artery disease	2.73e-06	5.85e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CETP—coronary artery disease	2.72e-06	5.82e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GCLC—coronary artery disease	2.72e-06	5.82e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GCLC—coronary artery disease	2.7e-06	5.79e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CETP—coronary artery disease	2.7e-06	5.79e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—MTHFR—coronary artery disease	2.69e-06	5.77e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SDC1—coronary artery disease	2.69e-06	5.75e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SDC1—coronary artery disease	2.67e-06	5.72e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS3—coronary artery disease	2.65e-06	5.67e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SULT1E1—coronary artery disease	2.63e-06	5.64e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—JAK2—coronary artery disease	2.57e-06	5.51e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AGT—coronary artery disease	2.56e-06	5.48e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PSMA6—coronary artery disease	2.54e-06	5.44e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PSMB5—coronary artery disease	2.54e-06	5.44e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.53e-06	5.43e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PSMB5—coronary artery disease	2.52e-06	5.41e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PSMA6—coronary artery disease	2.52e-06	5.41e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HK2—coronary artery disease	2.51e-06	5.38e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKR1B1—coronary artery disease	2.51e-06	5.38e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOE—coronary artery disease	2.51e-06	5.37e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—coronary artery disease	2.49e-06	5.34e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CTGF—coronary artery disease	2.48e-06	5.31e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOA1—coronary artery disease	2.48e-06	5.31e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CTGF—coronary artery disease	2.47e-06	5.28e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HMGCR—coronary artery disease	2.46e-06	5.26e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GOT2—coronary artery disease	2.46e-06	5.26e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HMGCR—coronary artery disease	2.44e-06	5.23e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GOT2—coronary artery disease	2.44e-06	5.23e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC27A1—coronary artery disease	2.41e-06	5.16e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NOS3—coronary artery disease	2.39e-06	5.11e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.37e-06	5.08e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LCAT—coronary artery disease	2.36e-06	5.06e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CPT1B—coronary artery disease	2.36e-06	5.06e-05	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	2.36e-06	5.06e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA4—coronary artery disease	2.32e-06	4.96e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLCB1—coronary artery disease	2.26e-06	4.84e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLCB1—coronary artery disease	2.25e-06	4.81e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PDHA1—coronary artery disease	2.24e-06	4.79e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GCLM—coronary artery disease	2.24e-06	4.79e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.22e-06	4.75e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.2e-06	4.72e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCA1—coronary artery disease	2.19e-06	4.69e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARG—coronary artery disease	2.18e-06	4.68e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—coronary artery disease	2.18e-06	4.67e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCA1—coronary artery disease	2.18e-06	4.66e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP11B2—coronary artery disease	2.17e-06	4.64e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TXNRD1—coronary artery disease	2.17e-06	4.64e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—POMC—coronary artery disease	2.15e-06	4.61e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.14e-06	4.57e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GOT1—coronary artery disease	2.12e-06	4.54e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GGT1—coronary artery disease	2.12e-06	4.54e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GOT1—coronary artery disease	2.11e-06	4.52e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GGT1—coronary artery disease	2.11e-06	4.52e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HADH—coronary artery disease	2.1e-06	4.51e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.1e-06	4.51e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2e-06	4.27e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPX2—coronary artery disease	2e-06	4.27e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA2—coronary artery disease	2e-06	4.27e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HK1—coronary artery disease	1.97e-06	4.22e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPX4—coronary artery disease	1.97e-06	4.22e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.97e-06	4.22e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.97e-06	4.22e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—coronary artery disease	1.96e-06	4.21e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HADHA—coronary artery disease	1.95e-06	4.17e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.93e-06	4.12e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—coronary artery disease	1.91e-06	4.08e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTP1—coronary artery disease	1.91e-06	4.08e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LPA—coronary artery disease	1.9e-06	4.08e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTP1—coronary artery disease	1.9e-06	4.06e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	1.89e-06	4.04e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HMOX1—coronary artery disease	1.88e-06	4.02e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NOS3—coronary artery disease	1.88e-06	4.02e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARGC1A—coronary artery disease	1.88e-06	4.02e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—coronary artery disease	1.87e-06	4.01e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HMOX1—coronary artery disease	1.87e-06	4e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CAT—coronary artery disease	1.85e-06	3.97e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CAT—coronary artery disease	1.84e-06	3.95e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.84e-06	3.95e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA5—coronary artery disease	1.82e-06	3.91e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—coronary artery disease	1.82e-06	3.89e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOB—coronary artery disease	1.8e-06	3.86e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOB—coronary artery disease	1.79e-06	3.83e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—P4HB—coronary artery disease	1.79e-06	3.83e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.76e-06	3.76e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTM1—coronary artery disease	1.75e-06	3.75e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TGFB1—coronary artery disease	1.75e-06	3.75e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTM1—coronary artery disease	1.74e-06	3.73e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LPL—coronary artery disease	1.72e-06	3.68e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—coronary artery disease	1.72e-06	3.68e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK1—coronary artery disease	1.72e-06	3.68e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LPL—coronary artery disease	1.71e-06	3.66e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPX1—coronary artery disease	1.68e-06	3.59e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPX1—coronary artery disease	1.67e-06	3.57e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—VCAN—coronary artery disease	1.66e-06	3.55e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.64e-06	3.52e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CD36—coronary artery disease	1.63e-06	3.5e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CD36—coronary artery disease	1.62e-06	3.48e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.61e-06	3.45e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPP2CA—coronary artery disease	1.6e-06	3.43e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—DCN—coronary artery disease	1.6e-06	3.42e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.55e-06	3.32e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.55e-06	3.31e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MTHFR—coronary artery disease	1.54e-06	3.3e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—coronary artery disease	1.53e-06	3.28e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.51e-06	3.24e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.51e-06	3.24e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HBA1—coronary artery disease	1.51e-06	3.24e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LIPC—coronary artery disease	1.51e-06	3.24e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOC3—coronary artery disease	1.5e-06	3.22e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LDLR—coronary artery disease	1.49e-06	3.2e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—coronary artery disease	1.49e-06	3.19e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—coronary artery disease	1.48e-06	3.18e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.48e-06	3.16e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.48e-06	3.16e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AGT—coronary artery disease	1.47e-06	3.15e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AGT—coronary artery disease	1.46e-06	3.13e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GCLC—coronary artery disease	1.46e-06	3.12e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CETP—coronary artery disease	1.46e-06	3.12e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SDC1—coronary artery disease	1.44e-06	3.09e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOE—coronary artery disease	1.44e-06	3.09e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOE—coronary artery disease	1.43e-06	3.07e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOA1—coronary artery disease	1.42e-06	3.05e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOA1—coronary artery disease	1.42e-06	3.03e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—coronary artery disease	1.41e-06	3.02e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.36e-06	2.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.36e-06	2.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.36e-06	2.92e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.36e-06	2.9e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—coronary artery disease	1.34e-06	2.87e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CTGF—coronary artery disease	1.33e-06	2.85e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.32e-06	2.83e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GOT2—coronary artery disease	1.32e-06	2.83e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARG—coronary artery disease	1.26e-06	2.69e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARG—coronary artery disease	1.25e-06	2.67e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—POMC—coronary artery disease	1.24e-06	2.65e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—POMC—coronary artery disease	1.23e-06	2.64e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—coronary artery disease	1.22e-06	2.61e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.21e-06	2.6e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.18e-06	2.52e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GOT1—coronary artery disease	1.14e-06	2.44e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GGT1—coronary artery disease	1.14e-06	2.44e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—coronary artery disease	1.13e-06	2.42e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—coronary artery disease	1.1e-06	2.35e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NOS3—coronary artery disease	1.08e-06	2.31e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NOS3—coronary artery disease	1.07e-06	2.3e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	1.06e-06	2.26e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.02e-06	2.19e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.01e-06	2.17e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.01e-06	2.16e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CAT—coronary artery disease	9.95e-07	2.13e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—coronary artery disease	9.87e-07	2.11e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—coronary artery disease	9.82e-07	2.1e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOB—coronary artery disease	9.66e-07	2.07e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTM1—coronary artery disease	9.4e-07	2.01e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LPL—coronary artery disease	9.23e-07	1.98e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPX1—coronary artery disease	9e-07	1.93e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CD36—coronary artery disease	8.77e-07	1.88e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8.66e-07	1.85e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—coronary artery disease	8.64e-07	1.85e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MTHFR—coronary artery disease	8.31e-07	1.78e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AGT—coronary artery disease	7.89e-07	1.69e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOE—coronary artery disease	7.73e-07	1.66e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA1—coronary artery disease	7.65e-07	1.64e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARG—coronary artery disease	6.74e-07	1.44e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—POMC—coronary artery disease	6.64e-07	1.42e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—coronary artery disease	6.07e-07	1.3e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—coronary artery disease	6.06e-07	1.3e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—coronary artery disease	6.04e-07	1.29e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NOS3—coronary artery disease	5.79e-07	1.24e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.3e-07	1.13e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—coronary artery disease	4.96e-07	1.06e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—coronary artery disease	4.93e-07	1.06e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.26e-07	6.98e-06	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—coronary artery disease	2.66e-07	5.7e-06	CbGpPWpGaD
